Echocardiography in Acute Myocardial Infarction

Diagnostic Applications

The European Society of Cardiology recommends that echocardiography be performed within 24-48 hours of presentation in all patients to establish baseline left ventricular function, detect mechanical complications, and guide therapeutic decisions 1, 2
Echocardiography changes therapy in 60-80% of acute cardiovascular patients and should be the first-line imaging modality when AMI is suspected but ECG findings are nondiagnostic, according to the European Heart Journal 1, 3
Regional wall motion abnormalities detected by echocardiography confirm myocardial ischemia/infarction when baseline ECG is nondiagnostic, with a 95-98% negative predictive value for excluding acute infarction when the study is normal, as reported by the Journal of the American College of Cardiology 4, 5
The American College of Cardiology states that in patients with acute chest pain and hemodynamic instability, echocardiography should be performed immediately as a bedside examination to identify the underlying cause and guide resuscitation 4, 6

The European Heart Journal recommends that transthoracic echocardiography must be performed within 24-48 hours after MI to establish baseline left ventricular ejection fraction (LVEF), which is the strongest predictor of survival in STEMI patients 2
For patients with clinical high-risk features, the European Heart Journal suggests that echocardiography should be performed immediately upon presentation rather than waiting 24-48 hours 6, 2

The European Society of Cardiology recommends that echocardiography serves as the basic imaging technique for measuring cardiac output, determining abnormalities of cardiac physiology and coronary perfusion, and monitoring therapeutic interventions in the coronary care unit and intensive care unit 1, 6
Echocardiography reveals the etiology of unexplained hypotension in 48% of medical intensive care patients and provides information additional to that obtained from pulmonary artery catheterization, according to the European Heart Journal 1, 3

The European Heart Journal states that second-generation contrast agents improve endocardial visualization and operator confidence in distinguishing acute heart failure due to systolic versus diastolic dysfunction, detecting post-infarction LV pseudoaneurysm, and identifying LV thrombus formation 6
The Journal of the American College of Cardiology recommends that echocardiography performed 2-10 days after AMI can distinguish nonviable myocardium from stunned myocardium, with viable segments showing augmentation of systolic wall thickening during low-dose dobutamine infusion 4

The American College of Cardiology advises that delaying echocardiography beyond 48 hours may miss early mechanical complications that require urgent surgical intervention—perform the study within 24-48 hours in all AMI patients 2
The European Heart Journal warns that relying solely on initial echocardiography without follow-up assessment in patients with LV dysfunction leads to missed opportunities for ICD therapy—always reassess LVEF at ≥40 days post-discharge 2